Cargando…

Serum calprotectin: A marker for early diagnosis of diabetic peripheral neuropathy

Detalles Bibliográficos
Autores principales:	Balasundaram, Mahesh Kumar, Sheth, Pranav G., Singh, Alok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797086/ https://www.ncbi.nlm.nih.gov/pubmed/35136815 http://dx.doi.org/10.4103/jfmpc.jfmpc_891_21

Ejemplares similares

Association of serum calprotectin with peripheral neuropathy in patients with type 2 diabetes mellitus
por: Velayutham, Ramanathan, et al.
Publicado: (2021)

Ultrasonography in the Early Diagnosis of Diabetic Lumbosacral Radiculoplexus Neuropathy
por: An, Jae Young, et al.
Publicado: (2019)

Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department
por: Bauer, Wolfgang, et al.
Publicado: (2021)

Need to Examine Postural Impairments in Diabetic Peripheral Neuropathy
por: Dixit, Snehil, et al.
Publicado: (2017)

Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients
por: Mentzer, Alexander J, et al.
Publicado: (2022)

Preservation of Ia afferent function in peripheral neuropathies
por: Burke, David, et al.
Publicado: (2021)

Treatment emergent peripheral neuropathy in the CASSIOPEIA trial
por: Fokkema, Cathelijne, et al.
Publicado: (2022)

Diabetic cardiac autonomic neuropathy in well-controlled diabetics within 1 year of diagnosis
por: Jawa, Ali, et al.
Publicado: (2011)

Is calprotectin a novel biomarker of neuroinflammation in diabetic periferal neuropathy?
por: Tabur, Suzan, et al.
Publicado: (2015)

Immune-Mediated Peripheral Neuropathy in Patients with Diffuse Panbronchiolitis
por: Kang, You-Ri, et al.
Publicado: (2020)

Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy
por: So, Wei Zheng, et al.
Publicado: (2022)

Peripheral Neuropathy in Sézary Syndrome: Coincidence or a Part of the Syndrome?
por: Karadağ, Yeşim S., et al.
Publicado: (2013)

Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy
por: Jeter, Ashley, et al.
Publicado: (2012)

Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia
por: Kavanagh, Simon, et al.
Publicado: (2018)

A case report of atypical ethylmalonic encephalopathy with peripheral neuropathy
por: Wang, Guan‐Qing, et al.
Publicado: (2023)

Serum Calprotectin Is a Potential Marker in Patients with Asthma
por: Lee, Yun-Gi, et al.
Publicado: (2020)

Electrodiagnostics or Ultrasound for Diagnosing Diabetic Peripheral Neuropathy [Letter]
por: Hernandez Fustes, Otto Jesus, et al.
Publicado: (2021)

What calprotectin cut-offs should apply for IBD in general practice?
por: Landis, Darryl, et al.
Publicado: (2016)

A meta-analysis of the association between calprotectin and the severity of COVID-19
por: Mao, Qin, et al.
Publicado: (2022)

DRESS Syndrome with Peripheral Neuropathy Due to Reactivation of Cytomegalovirus in a Child
por: Vasanthan, Tanigasalam, et al.
Publicado: (2015)

Type of Chemotherapy-Induced Peripheral Neuropathy, Influencing Factors, and Functional Status
por: HAN, Jeong-won, et al.
Publicado: (2015)

Letters to the editor: Nicotinic acetylcholine receptor ligands as potential targets for managing neuropathic pain induced by diabetic peripheral neuropathy
por: Westlake, Sarah, et al.
Publicado: (2022)

Applicability of High-Frequency Ultrasound to the Early Diagnosis of Diabetic Peripheral Neuropathy
por: Ma, Xishun, et al.
Publicado: (2021)

Hindrance and Possible Solutions of Conducting a Clinical Trial: A Student's Perspective
por: Balasundaram, Mahesh Kumar, et al.
Publicado: (2022)

Chemotherapy-Induced or Chemotherapy-Associated? Does Physical Therapy Play a Role in Prevention and/or Management of Peripheral Neurotoxicity and Neuropathy?
por: Kumar, Senthil Paramasivam, et al.
Publicado: (2013)

Serum leptin levels and peripheral arterial stiffness in patients with type 2 diabetes
por: Yasri, Sora, et al.
Publicado: (2019)

Peripheral neuropathy in a family with Sandhoff disease and SH3TC2 deficiency
por: Grunseich, Christopher, et al.
Publicado: (2015)

Molsidomine ameliorates diabetic peripheral neuropathy complications in Wistar rats
por: Nayak B, Pranav, et al.
Publicado: (2021)

Role of Peroxynitrite in the Development of Diabetic Peripheral Neuropathy
por: Edwards, Joshua F., et al.
Publicado: (2015)

Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection()()
por: O'Moráin, N, et al.
Publicado: (2022)

Multiple Cranial Neuropathies in a Patient with Diabetes Mellitus
por: Mathew, Jomal, et al.
Publicado: (2019)

Implication of Local Plantar Vibration in Patients with Diabetic Neuropathy
por: Sabziparvar, Mahsa, et al.
Publicado: (2022)

Association Between Early Markers of Renal Injury and Type 2 Diabetic Peripheral Neuropathy
por: Yang, Zhi, et al.
Publicado: (2021)

Viloxazine for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis of Randomized Clinical Trials
por: Singh, Alok, et al.
Publicado: (2022)

Diagnosis of peripheral neuropathy
por: Lehmann, Helmar C., et al.
Publicado: (2020)

Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
por: Bayrakci, Nergiz, et al.
Publicado: (2022)

Clinical Profile of Patients with Leber Hereditary Optic Neuropathy—An Ambispective Study in Cohort from Northern Part of India
por: Wilson, Vinny, et al.
Publicado: (2023)

Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies
por: Lamotte, Guillaume, et al.
Publicado: (2022)

Isolated peripheral facial nerve palsy post COVID-19 vaccination with complete clinical recovery
por: Ish, Somya, et al.
Publicado: (2022)

Comment on: “Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs”
por: Eerdekens, M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i2qeislt3odm99om567me16it5